Advertisement
Screener

BioCardia, Inc. (BCDA) Graph

BCDA Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue (m); Revenue including tax (m); Cost of revenue (m); Research and development $893.00K.
  • 2026-03-31: Revenue (m); Revenue including tax (m); Cost of revenue (m); Research and development $1.24M.
  • 2025-12-31: Revenue (m); Revenue including tax $0.00*; Cost of revenue (m); Research and development $1.13M*.
  • 2025-09-30: Revenue (m); Revenue including tax $0.00; Cost of revenue (m); Research and development $936.00K.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30(m)(m)(m)$893.00K$730.00K$0.00-$1.61M
2026-03-31(m)(m)(m)$1.24M$1.03M$0.00-$2.26M
2025-12-31(m)$0.00*(m)$1.13M*$885.00K*$0.00*-$1.98M*
2025-09-30(m)$0.00(m)$936.00K$552.00K$0.00-$1.48M
2025-06-30(m)$0.00(m)$1.37M$683.00K$0.00-$2.05M
2025-03-31(m)$0.00(m)$1.53M$1.20M$0.00-$2.71M
2024-09-30(m)$0.00(m)$931.00K$825.00K$0.00-$1.74M
2024-06-30(m)$3.00K(m)$800.00K$852.00K$0.00-$1.65M
2024-03-31(m)$55.00K(m)$1.24M$1.09M$0.00-$2.27M
2023-09-30(m)$357.00K(m)$1.87M$1.08M$0.00-$2.57M
2023-06-30(m)$43.00K(m)$2.31M$1.18M$0.00-$3.42M
2023-03-31(m)$64.00K(m)$2.38M$1.19M$0.00-$3.50M
2022-09-30(m)$212.00K(m)$2.14M$1.13M(m)-$3.06M
2022-06-30(m)$974.00K(m)$2.30M$1.17M(m)-$2.50M
2022-03-31(m)$60.00K(m)$2.19M$1.20M$0.00-$3.33M
2021-12-31(m)(m)$0.00*(m)(m)(m)(m)
2021-09-30(m)$821.00K$0.00$2.24M$1.29M$0.00-$2.71M
2021-06-30(m)$69.00K$0.00$2.36M$1.20M$0.00-$3.49M
2021-03-31(m)$46.00K(m)$1.84M$1.18M$0.00-$2.97M
2020-09-30(m)$34.00K$0.00$2.47M$1.41M$0.00-$3.85M
2020-06-30(m)$27.00K$0.00$2.22M$1.38M$0.00-$3.57M
2020-03-31(m)$38.00K$4.00K$2.79M$1.86M$0.00-$4.59M
2019-09-30(m)$194.00K$24.00K$2.01M$1.39M$0.00-$3.79M
2019-06-30(m)$86.00K$191.00K$2.22M$1.44M$0.00-$3.75M
2019-03-31(m)$216.00K$106.00K$2.17M$1.63M$0.00-$3.67M
2018-09-30(m)$84.00K$109.00K$2.26M$1.28M$0.00-$3.54M
2018-06-30(m)$239.00K$135.00K$2.03M$1.32M$0.00-$3.22M
2018-03-31(m)$199.00K$157.00K$1.96M$1.71M$0.00-$3.58M
2017-12-31$100.00K*(m)(m)(m)(m)(m)(m)
2017-09-30$130.00K$130.00K$147.00K$1.70M$1.32M(m)-$3.00M
2017-06-30$112.00K$112.00K$203.00K$1.29M$1.58M(m)-$2.94M
2017-03-31$137.00K$137.00K$175.00K$1.03M$1.80M$0.00-$2.88M
2016-09-30$117.00K(m)(m)$684.00K$919.00K$0.00-$3.25M
2016-06-30$144.00K(m)(m)$497.00K$869.00K$0.00-$1.98M
2016-03-31$178.00K(m)(m)$441.00K$587.00K$0.00-$1.50M
2015-09-30(m)(m)(m)(m)(m)$0.00$83.00K
2015-06-30(m)(m)(m)(m)(m)$0.00$73.00K
2015-03-31(m)(m)(m)(m)(m)$0.00$76.00K
2014-09-30(m)(m)(m)(m)(m)$0.00$43.00K
2014-06-30(m)(m)(m)(m)(m)$0.00$66.00K
2014-03-31(m)(m)(m)(m)(m)$0.00$64.00K
2013-09-30(m)(m)(m)(m)(m)$0.00$30.00K
2013-06-30(m)(m)$0.00(m)(m)$0.00$9.00K
2013-03-31(m)(m)$0.00(m)(m)$0.00-$25.00K
2012-12-31(m)(m)$0.00*(m)(m)(m)(m)
2012-09-30$19.00K(m)$0.00(m)(m)$0.00$451.00K
2012-06-30$17.00K(m)$0.00(m)(m)$0.00-$129.00K
2012-03-31$11.00K(m)$0.00(m)(m)$0.00-$55.00K
2011-09-30$0.00(m)$0.00(m)(m)$0.00-$561.00K
2011-06-30$0.00(m)$0.00(m)(m)$0.00$10.84M
2011-03-31$0.00(m)$0.00(m)(m)$0.00-$321.00K
2010-09-30$0.00(m)$0.00(m)(m)$0.00-$8.11M
2010-06-30$0.00(m)$0.00(m)(m)$0.00-$1.48M

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30(m)(m)(m)$2.13M$1.76M$0.00-$3.87M
2025-06-30(m)$0.00(m)$2.90M$1.88M$0.00-$4.76M
2024-06-30(m)$58.00K(m)$2.04M$1.94M$0.00-$3.91M
2023-06-30(m)$107.00K(m)$4.70M$2.37M$0.00-$6.92M
2022-06-30(m)$1.03M(m)$4.49M$2.37M$0.00-$5.82M
2021-06-30(m)$115.00K$0.00$4.20M$2.37M$0.00-$6.46M
2020-06-30(m)$65.00K$4.00K$5.01M$3.23M$0.00-$8.17M
2019-06-30(m)$302.00K$297.00K$4.38M$3.07M$0.00-$7.42M
2018-06-30(m)$438.00K$292.00K$3.99M$3.03M$0.00-$6.80M
2017-06-30$249.00K$249.00K$378.00K$2.33M$3.39M$0.00-$5.82M
2016-06-30$322.00K(m)(m)$938.00K$1.46M$0.00-$3.47M
2015-06-30(m)(m)(m)(m)(m)$0.00$149.00K
2014-06-30(m)(m)(m)(m)(m)$0.00$130.00K
2013-06-30(m)(m)$0.00(m)(m)$0.00-$16.00K
2012-06-30$28.00K(m)$0.00(m)(m)$0.00-$184.00K
2011-06-30$0.00(m)$0.00(m)(m)$0.00$10.52M
2010-06-30$0.00(m)$0.00(m)(m)$0.00-$2.94M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30(m)$0.00(m)$3.83M$2.43M$0.00-$6.24M
2024-09-30(m)$58.00K(m)$2.97M$2.77M$0.00-$5.65M
2023-09-30(m)$464.00K(m)$6.57M$3.45M$0.00-$9.50M
2022-09-30(m)$1.25M(m)$6.63M$3.50M$0.00-$8.88M
2021-09-30(m)$936.00K$0.00$6.44M$3.66M$0.00-$9.16M
2020-09-30(m)$99.00K$4.00K$7.48M$4.64M$0.00-$12.02M
2019-09-30(m)$495.00K$321.00K$6.39M$4.46M$0.00-$11.21M
2018-09-30(m)$522.00K$401.00K$6.25M$4.32M$0.00-$10.35M
2017-09-30$379.00K$379.00K$525.00K$4.03M$4.71M$0.00-$8.82M
2016-09-30$439.00K(m)(m)$1.62M$2.38M$0.00-$6.73M
2015-09-30(m)(m)(m)(m)(m)$0.00$232.00K
2014-09-30(m)(m)(m)(m)(m)$0.00$173.00K
2013-09-30(m)(m)(m)(m)(m)$0.00$14.00K
2012-09-30$47.00K(m)$0.00(m)(m)$0.00$267.00K
2011-09-30$0.00(m)$0.00(m)(m)$0.00$9.95M
2010-09-30$0.00(m)$0.00(m)(m)$0.00-$11.05M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31(m)$0.00(m)$4.96M$3.32M$0.00-$8.23M
2024-12-31(m)$58.00K(m)$4.39M$3.67M$0.00-$7.95M
2023-12-31(m)$477.00K(m)$7.73M$4.39M$0.00-$11.57M
2022-12-31(m)$1.35M(m)$8.83M$4.42M$0.00-$11.91M
2021-12-31(m)$1.01M$0.00$8.56M$5.09M$0.00-$12.62M
2020-12-31(m)$145.00K$4.00K$9.81M$5.86M$0.00-$15.00M
2019-12-31(m)$710.00K$358.00K$8.56M$6.00M$0.00-$14.71M
2018-12-31(m)$625.00K$517.00K$8.45M$5.76M$0.00-$13.99M
2017-12-31$479.00K$479.00K$690.00K$5.80M$6.39M$0.00-$12.31M
2016-12-31$576.00K$576.00K$746.00K$3.33M$4.11M$0.00-$10.31M
2015-12-31$904.00K(m)(m)$1.52M$3.73M$0.00-$6.70M
2014-12-31(m)(m)(m)(m)(m)$0.00$234.00K
2013-12-31(m)(m)(m)(m)(m)$0.00$19.00K
2012-12-31(m)(m)$0.00(m)(m)$0.00$305.00K
2011-12-31$12.00K(m)$0.00(m)(m)(m)$9.66M
2010-12-31$0.00(m)$0.00(m)(m)(m)-$11.51M

Similar stocks

Stock NameCountryMarket CapPE Ratio
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23